Biological characteristics of foam cell formation in smooth muscle cells derived from Bone Marrow stem cells

International Journal of Biological Sciences

Volumn 7, Issue 7, 2011, Pages 937-946

  Yan, Pengke ^a   Xia, Chenglai ^a   Duan, Caiwen ^b   Li, Shihuang ^c   Mei, Zhengrong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c Chenzhou Fourth People's Hospital   (China)

Author keywords

ABCA1; Atherosclerosis; Bone marrow mesenchymal stem cells; Caveolin 1; SR A; Vascular smooth muscle cells

Indexed keywords

EID: 80052721559     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.937     Document Type: Article

References (36)

1. Tabas I. Macrophage death and defective inflammation resolu-tion in atherosclerosis. Nat Rev Immunol. 2010;10(1):36-46.
2. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the patho-genesis of atherosclerosis. Nat Med. 2002;8(4):403-409.
3. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364(18):1746-1760.
4. Cheong A, Li J, Sukumar P, et al. Potent suppression of vascular smooth muscle cell migration and human neointimal hyper-plasia by KV1.3 channel blockers. Cardiovasc Res. 2011;89(2):282-289.
5. Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov. 2011;10(5):365-376.
6. Barry FP, Murphy JM. Mesenchymal stem cells: clinical appli-cations and biological characterization. Int J Biochem Cell Biol 2004; 36:568-584.
7. Baksh D, Yao R, Tuan RS, et al. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392.
8. Zhang F, Tsai S, Kato K, et al. Transforming growth factor-beta promotes recruitment of bone marrow cells and bone mar-row-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem 2009; 284:17564-17574.
9. Yamazaki S, Iwama A, Takayanagi S, et al. TGF-beta as a can-didate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 2009;113(6):1250-1256.
10. Ishijima M, Tsuji K, Rittling SR, et al. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells. J Endocrinol. 2007;193(2):235-243.
11. Maltais S, Perrault LP, Ly HQ. The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure. Eur J Cardi-othorac Surg. 2011;39(3):368-374.
12. Fadini GP, Tjwa M, et al. A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis. 2010;211(1):32-35.
13. Kim HJ, Yoo EK, Kim JY, et al. Protective role of cluster-in/apolipoprotein J against neointimal hyperplasia via anti-proliferative effect on vascular smooth muscle cells and cyto-protective effect on endothelial cells. Arterioscler Thromb Vasc Biol. 2009;29(10):1558-1564.
14. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001; 7:738-741.
15. Chen S, Lechleider RJ. Transforming growth fac-tor-beta-induced differentiation of smooth muscle from a neu-ral crest stem cell line. Circ Res. 2004;94(9):1195-1202.
16. Azari BM, Marmur JD, Salifu MO et al. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of in-flamed vascular smooth muscle cells and in atherosclerosis. Atherosclerosis. 2010;212(1):197-205.
17. Frank PG. Endothelial caveolae and caveolin-1 as key regula-tors of atherosclerosis. Am J Pathol. 2010;177(2):544-546.
18. Hristov M, Zernecke A, Schober A, et al. Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem. 2008;389(7):837-844.
19. Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular dis-ease. J Cell Mol Med 2005; 9:583-591.
20. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007; 27:1248-1258.
21. Medbury HJ, Tarran SL, Guiffre AK, et al. Monocytes contrib-ute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 2008; 27:114-123.
22. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7:1035-1040.
23. Tian L, Luo N, Klein RL, et al. Adiponectin reduces lipid ac-cumulation in macrophage foam cells. Atherosclerosis. 2009; 202(1):152-161.
24. Ho HH, Hsu LS, Chan KC, et al. Extract from the leaf of nucif-era reduced the development of atherosclerosis via inhibition of vascular smooth muscle cell proliferation and migration. Food Chem Toxicol 2010; 48:159-168.
25. Silverstein RL, Li W, Park YM, et al. Mechanisms of cell sig-naling by the scavenger receptor CD36: implications in athero-sclerosis and thrombosis. Trans Am Clin Climatol Assoc. 2010;121: 206-220.
26. Van Eck M, Singaraja RR, Ye D, et al. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knock-out mice. Arterioscler Thromb Vasc Biol 2006; 26:929-934.
27. Choi HY, Rahmani M, Wong BW, et al. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circula-tion 2009; 119:3223-3231.
28. Chang SH, Feng D, Nagy JA, et al. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol. 2009;175(4):1768-1776.
29. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293:2449-2452.
30. Hu Q, Zhang XJ, Liu CX, et al. PPARgamma1-induced caveo-lin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice. J Vasc Res. 2010;47(1):69-79.
31. Truong TQ, Aubin D, Falstrault L, et al. SR-BI, CD36, and caveolin-1 contribute positively to cholesterol efflux in hepatic cells. Biol Chem. 2008;389(7):837-844.
32. Yan PK, Duan CW, Li SH, et al. Effect of oxidative low-density lipoprotein on the proliferation of bone marrow stem cell-derived smooth muscle cells. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30(5):989-992.
33. Keramati AR, Singh R, Lin A, Faramarzi S, et al. Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C in-creases PDGF-dependent vascular smooth muscle cell prolifer-ation. Proc Natl Acad Sci U S A. 2011;108(5):1914-1918.
34. Luo DX, Xia CL, Li JM, et al. Static pressure accelerates ox-LDL-induced cholesterol accumulation via SREBP-1-mediated caveolin-1 downregulation in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 2010;403(1):52-58.
35. Yuan HY, Kuang SY, Zheng X et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin. 2008; 29:555-563.
36. Wang B, Omar A, Angelovska T, et al. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 2007; 293:H1282-1290.